Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer.
Ann Oncol
; 33(5): 500-510, 2022 05.
Article
in En
| MEDLINE
| ID: mdl-35306155
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Small Cell Lung Carcinoma
/
Circulating Tumor DNA
/
Lung Neoplasms
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Limits:
Humans
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2022
Document type:
Article
Affiliation country: